Valion Bio Announces That The Pentagon's Armed Forces Radiobiology Research Institute And National Institute of Allergy and Infectious Diseases Completed Their Design Of Survival Efficacy Protocol To Evaluate The Company's Entolimod To Treat Gastrointestinal Acute Radiation Syndrome

뉴스 본문을 불러오고 있어요.

Valion Bio Announces That The Pentagon's Armed Forces Radiobiology Research Institute And National Institute of Allergy and Infectious Diseases Completed Their Design Of Survival Efficacy Protocol To Evaluate The Company's Entolimod To Treat Gastrointestinal Acute Radiation Syndrome | 웨이프 WAPE

Valion Bio Announces That The Pentagon's Armed Forces Radiobiology Research Institute And National Institute of Allergy and Infectious Diseases Completed Their Design Of Survival Efficacy Protocol To Evaluate The Company's Entolimod To Treat Gastrointestinal Acute Radiation Syndrome

기사 요약

관련 종목

댓글 —